Opinion|Videos|May 5, 2025
From AAD 2025 to the Future: Advancements in Dermatology to Watch
A panelist discusses how the evolving landscape of atopic dermatitis treatment is moving toward a more personalized approach that carefully balances efficacy goals with safety considerations, incorporating new targeted therapies alongside traditional options while also expressing excitement about emerging research in dermatology including novel bispecific antibodies, microbiome-based interventions, and noninvasive diagnostic technologies that may revolutionize disease management in the coming years.
Advertisement
Episodes in this series
- How do you envision the treatment of atopic dermatitis evolving, particularly regarding the balance between efficacy, safety, and patient management?
- Please discuss any other data in the scope of dermatology released at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) that you find noteworthy to share with colleagues.
- Outside of AAD 2025, what ongoing research efforts are you most excited for in the treatment and management of dermatologic conditions? What can we look forward to through the end of the year and beyond?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Medicaid MFN Pricing Could Save $8.6 Billion
2
Active US Drug Shortages Rise for Third Straight Quarter
3
Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia
4
FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance
5